InsidersTradesSigma
Follow the 코미팜 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 코미팜 has published 7 public disclosures. The latest transaction was filed on 21 October 2022 (Purchase). Among the most active insiders: 코미팜. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
코미팜 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative drugs and therapeutic solutions.